RIT biomedical engineering researchers identify a protein that can reduce fibrosis and slow disease progression.
Hypertrophic scars remain one of the most persistent challenges in wound healing, often resulting in excessive fibrosis, disfigurement, and long-term functional impairment. Researchers now report a ...
TEL AVIV, Israel, Sept. 26, 2023 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and fibrotic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results